Nucleic Acids Research, 2003, Vol. 31, No. 5 1571-1575
© 2003 Oxford University Press
Transcriptional activation by AP-2
is modulated by the oncogene DEK
Centro de Biología Molecular ‘Severo Ochoa’, CSIC-Universidad Autónoma de Madrid, 28049 Cantoblanco, Madrid, Spain
*To whom correspondence should be addressed. Tel: +34 913 978364; Fax: +34 913 978087; Email: jvazquez{at}cbm.uam.es
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
Cell differentiation and development are highly regulated processes at the transcriptional level. One of the main transcription factors that regulate these processes is AP-2
, a cell-type specific protein required for vertebrate development and embryogenesis. AP-2 also regulates apoptosis and cell-cycle specific events by interacting with the oncogene c-Myc. In searching for novel AP-2- interacting factors, using an affinity chromatography approach, we have observed that oncoprotein DEK interacts with AP-2 in vitro. The existence of an interaction between AP-2 and DEK in cellular cultures was demonstrated by expression of a tagged AP-2 form followed by immunodetection. By transient co-expression experiments using a reporter for APOE promoter activity we have found that DEK stimulates the transactivation activity of AP-2 over APOE promoter. Finally, electrophoretic mobility shift assays suggested that DEK enhances the DNA-binding activity of AP-2. Our data suggest a novel cellular function of DEK as a transcriptional co-activator.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. M. Wise-Draper, R. A. Mintz-Cole, T. A. Morris, D. S. Simpson, K. A. Wikenheiser-Brokamp, M. A. Currier, T. P. Cripe, G. C. Grosveld, and S. I. Wells Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo Cancer Res., March 1, 2009; 69(5): 1792 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wise-Draper, R. J. Morreale, T. A. Morris, R. A. Mintz-Cole, E. E. Hoskins, S. J. Balsitis, N. Husseinzadeh, D. P. Witte, K. A. Wikenheiser-Brokamp, P. F. Lambert, et al. DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program Am. J. Pathol., January 1, 2009; 174(1): 71 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kappes, J. Fahrer, M. S. Khodadoust, A. Tabbert, C. Strasser, N. Mor-Vaknin, M. Moreno-Villanueva, A. Burkle, D. M. Markovitz, and E. Ferrando-May DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress Mol. Cell. Biol., May 15, 2008; 28(10): 3245 - 3257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Wise-Draper, H. V. Allen, E. E. Jones, K. B. Habash, H. Matsuo, and S. I. Wells Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions Mol. Cell. Biol., October 15, 2006; 26(20): 7506 - 7519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sammons, S. S. Wan, N. L. Vogel, E. J. Mientjes, G. Grosveld, and B. P. Ashburner Negative Regulation of the RelA/p65 Transactivation Function by the Product of the DEK Proto-oncogene J. Biol. Chem., September 15, 2006; 281(37): 26802 - 26812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Mitchell, M. Abdelrahim, J. Weng, L. J. Stafford, S. Safe, M. Bar-Eli, and M. Liu Regulation of KiSS-1 Metastasis Suppressor Gene Expression in Breast Cancer Cells by Direct Interaction of Transcription Factors Activator Protein-2{alpha} and Specificity Protein-1 J. Biol. Chem., January 6, 2006; 281(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ding, C. Fan, J. Zhou, Y. Zhong, R. Liu, K. Ren, X. Hu, C. Luo, S. Xiao, Y. Wang, et al. GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic Acids Res., January 1, 2006; 34(9): 2570 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wise-Draper, H. V. Allen, M. N. Thobe, E. E. Jones, K. B. Habash, K. Munger, and S. I. Wells The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7 J. Virol., November 15, 2005; 79(22): 14309 - 14317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-g. Hu, H. Illges, C. Gruss, and R. Knippers Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes Int. Immunol., June 1, 2005; 17(6): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Böhm, F. Kappes, I. Scholten, N. Richter, H. Matsuo, R. Knippers, and T. Waldmann The SAF-box domain of chromatin protein DEK Nucleic Acids Res., February 18, 2005; 33(3): 1101 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kappes, I. Scholten, N. Richter, C. Gruss, and T. Waldmann Functional Domains of the Ubiquitous Chromatin Protein DEK Mol. Cell. Biol., July 1, 2004; 24(13): 6000 - 6010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kappes, C. Damoc, R. Knippers, M. Przybylski, L. A. Pinna, and C. Gruss Phosphorylation by Protein Kinase CK2 Changes the DNA Binding Properties of the Human Chromatin Protein DEK Mol. Cell. Biol., July 1, 2004; 24(13): 6011 - 6020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Waldmann, M. Baack, N. Richter, and C. Gruss Structure-specific binding of the proto-oncogene protein DEK to DNA Nucleic Acids Res., December 1, 2003; 31(23): 7003 - 7010. [Abstract] [Full Text] [PDF]
|
|